Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joinn Laboratories (China) CoSHSE:603127 +3.72%78 Gross Margin % is 20.49% as of Mar. 2026, which is 59% below its 10-year median of 49.60. GuruFocus rates SHSE:603127 with a GF Score™ of 78/100 and a GF Value™ of ¥17.43 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Joinn Laboratories (China) Co ranks worse than 88.66% on this metric.
SHSE:603127's Gross Margin % is ranked worse than 88.66% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 51.445
vs SHSE:603127: 19.32
Joinn Laboratories (China) Co had a gross margin of 20.49% for the quarter that ended in Mar. 2026 => Competition eroding margins
Joinn Laboratories (China) Co (SHSE:603127) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Joinn Laboratories (China) Co had a gross margin of 20.49% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Joinn Laboratories (China) Co Gross Margin % Related Terms
Joinn Laboratories (China) Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joinn Laboratories (China) Co Gross Margin % Chart
SHSE:603127 vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joinn Laboratories (China) Co Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Joinn Laboratories (China) Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Joinn Laboratories (China) Co (SHSE:603127) has a Gross Margin % of 20.49% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Joinn Laboratories (China) Co and its competitors. This is 59% below median its historical median of 49.60. Over the past decade, Joinn Laboratories (China) Co's Gross Margin % has ranged from 19.32 to 56.27. According to the industry distribution chart, Joinn Laboratories (China) Co ranks #172 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 88.7%.
Is Joinn Laboratories (China) Co's Gross Margin % too high?
Joinn Laboratories (China) Co's current Gross Margin % of 20.49% is 59% below median its 10-year median of 49.60. Over the past 10 years, this metric has ranged from a low of 19.32 to a high of 56.27. The Medical Diagnostics & Research industry median Gross Margin % is 51.45. Joinn Laboratories (China) Co's value of 20.49% is 60.2% below this industry median. Based on the distribution chart, Joinn Laboratories (China) Co ranks #172 out of 194 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Joinn Laboratories (China) Co has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Joinn Laboratories (China) Co's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Joinn Laboratories (China) Co ranks #172 out of 194 companies for Gross Margin %. This places Joinn Laboratories (China) Co in the lower half of its industry. The industry median Gross Margin % is 51.45. Joinn Laboratories (China) Co's value of 20.49% is 60.2% below this benchmark. Historically, Joinn Laboratories (China) Co's own Gross Margin % has ranged from 19.32 to 56.27 over the past decade. While the company's 10-year median is 49.60 vs. the industry median of 51.45, Joinn Laboratories (China) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.45, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joinn Laboratories (China) Co's current Gross Margin % of 20.49% is 60.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Joinn Laboratories (China) Co and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joinn Laboratories (China) Co's current Gross Margin % is 20.49%, which is 59% below median its own 10-year median of 49.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joinn Laboratories (China) Co stock overvalued right now?
Based on GuruFocus' analysis, Joinn Laboratories (China) Co (SHSE:603127) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.43, compared to a current price of ¥41.54 — trading 138.3% above its estimated fair value. The current Gross Margin % is 20.49%, which is 59% below median its 10-year median of 49.60 and 60.2% below the Medical Diagnostics & Research industry median of 51.45. Joinn Laboratories (China) Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Joinn Laboratories (China) Co (SHSE:603127), the current Gross Margin % is 20.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joinn Laboratories (China) Co (SHSE:603127) Overvalued in 2026?
Based on GuruFocus' analysis, Joinn Laboratories (China) Co stock appears to be overvalued.
The current stock price of ¥41.54 is trading 138.3% above its estimated GF Value™ of ¥17.43.
GuruFocus considers Joinn Laboratories (China) Co to be Significantly Overvalued.
Key valuation signals for SHSE:603127:
Gross Margin %: 20.49% (59% below median its 10-year median of 49.60)
GF Value™: ¥17.43 vs. price of ¥41.54 (138.3% above fair value)
Industry Position: 60.2% below the Medical Diagnostics & Research median (#172 of 194)
No single metric tells the full story. See the SHSE:603127 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Joinn Laboratories (China) Co Ltd is a PRC-based company, along with its subsidiary, it is engaged in contract research organisation (CRO) services. It operates in three segments: Non-clinical studies services offer drug safety assessment, drug metabolism and pharmacokinetics (DMPK) studies, and pharmacology and efficacy studies; Clinical trial & related services provide clinical CRO services, co-managed phase I clinical research units, and bioanalytical servicesl services; and Sales of research models engages in the design, production, breeding and sales of research models, non-human primates and rodents. The majority of revenue comes from the Non-Clinical studies services. Its geographical areas are China, the United States, and Other countries, of which the majority are from China.
78GF Score
Get the complete analysis for SHSE:603127
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603127 has been successfully added to your 
